Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
GlaxoSmithKline Trading Services Limited
ATC Code
R03AL08
Source
EMA · EMEA/H/C/004363
(
ARTG
)
Asthma,TRELEGY ELLIPTA is indicated for the maintenance treatment of asthma in adult patients who are not adequately controlled with a combination of inhaled corticosteroid and a long-acting beta2-agonist.,COPD,TRELEGY ELLIPTA is indicated for the maintenance treatment of adults with moderate to severe COPD who require treatment with LAMA+LABA+ICS.,TRELEGY ELLIPTA is not indicated for the initiation of therapy in COPD.
⚠️ Warnings
•
Inhaler
• Caution should be exercised in patients with history of tuberculosis, cataract, increased eye pressure, infections, kidney or liver disease, diarrhea, who are taking other medications, any allergy, children, during pregnancy and breastfeeding.
• Always keep the inhaler hand in hand.
• It may cause loss of blood electrolytes, infection, due to change from oral steroids to inhaler. If you experience with any of the above symptoms, consult with your doctor immediately.
• Patients should stay away from people who are affected by certain infections like chickenpox or measles if they have not been vaccinated.
Topical
• Do not cover the treated skin after applying this medication.
• Caution needed for pregnant and breastfeeding women.
• Wash your hands thoroughly after applying this medication.
• For external use only.
